Corcept Therapeutics (CORT) Change in Acquisitions & Divestments (2017 - 2026)

Corcept Therapeutics has reported Change in Acquisitions & Divestments for 10 years, with the latest figure at $62.2 million in Q2 2026.

• Quarterly Change in Acquisitions & Divestments fell 33.4% year-over-year to $62.2 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $303.4 million (down 34.99% YoY) and the FY2025 annual result came in at $389.6 million, down 5.64% from the prior year.
• Change in Acquisitions & Divestments grew to $62.2 million in Q2 2026 per CORT's latest filing, from $57.1 million in the prior quarter.
• Over five years, Change in Acquisitions & Divestments peaked at $207.5 million in Q1 2023 and troughed at $42.1 million in Q1 2022.
• A 5-year average of $87.9 million and a median of $76.9 million in 2022 frame the typical range for Change in Acquisitions & Divestments.
• The sharpest annual moves came in 2023 and 2025: Change in Acquisitions & Divestments surged 392.5% in 2023, then plunged 71.23% in 2025.
• Over 5 years, Change in Acquisitions & Divestments stood at $79.4 million in 2022, then sank by 40.83% to $47.0 million in 2023, then soared by 70.92% to $80.3 million in 2024, then surged by 64.37% to $132.0 million in 2025, then plunged by 52.86% to $62.2 million in 2026.
• According to Business Quant data, Change in Acquisitions & Divestments over the past three periods registered $62.2 million, $57.1 million, and $132.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.